all report title image

MICROBIOME SEQUENCING SERVICE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Microbiome Sequencing Service Market, By Service Type (6S rRNA gene profiling, Whole genome shotgun sequencing, Targeted gene sequencing, Single-cell sequencing, and Others), By Application (Gut microbiome analysis, Urinary microbiome analysis, and Others), By End User (Academic and research institutes, Pharmaceutical and Biotechnology companies, Diagnostic laboratories, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : May 2024
  • Code : CMI6980
  • Pages :140
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

Regional Analysis

Microbiome Sequencing Service Market Regional Insights

To learn more about this report, Request sample copy

North America remains the dominant region in the global microbiome sequencing service market and is estimated to hold 37.4% of the market share in 2024 due to the presence of prominent market players and strong healthcare research infrastructure. Most of the leading service providers such as Illumina, Qiagen, and CosmosID are headquartered in the U.S. and have extensive operations across the region to cater to the high demand. In addition, North America hosts R&D centers of several pharmaceutical and biotechnology companies that employ microbiome sequencing services for drug discovery and development activities. The region also has a favorable reimbursement environment and growing awareness about clinical applications of microbiome research which drives the market growth. Furthermore, the thriving academics ecosystem in the U.S. and Canada contributes significantly through funded research projects involving microbiome sequencing.

Asia Pacific has emerged as the fastest growing regional market for microbiome sequencing services. Countries such as China, Japan, South Korea, and India offer immense opportunities for market expansion owing to rise in healthcare investments, increasing focus on preventive medicines, and growing collaboration between regional and global players. Local players in Asia are investing heavily to establish themselves through partnerships, acquisitions and by expanding their portfolio. This has encouraged technology transfer and enhanced accessibility of advanced sequencing technologies. Moreover, the low labor and operating costs make the region an attractive outsourcing destination for large sequencing projects. Rising disposable income has also increased affordability of such specialized services. Several global service providers now have established regional hubs and local partner laboratories across major Asian countries to capitalize on this fast-paced growth.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.